Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
Advertisement
Articles by Nicholas J. Vogelzang, MD, FASCO, FACP, Comprehensive Cancer Centers of Nevada
Advertisement
Latest Updated Articles
Patient’s Role in Decision-Making for Prostate CancerPublished: September 16th 2020 | Updated:
Impact of BRCA Mutations in Prostate CancerPublished: September 16th 2020 | Updated:
Quality of Life With Prostate CancerPublished: September 16th 2020 | Updated:
The Future of PARP Inhibitors in Prostate CancerPublished: September 16th 2020 | Updated:
Diagnosis of Prostate CancerPublished: September 16th 2020 | Updated:
FDA Approved PARP Inhibitors for Prostate CancerPublished: September 16th 2020 | Updated:
Advertisement
Advertisement
Trending on CURE
1
Verzenio Plus Endocrine Therapy Benefits Survival for Some With Breast Cancer
2
Stage 1 Multiple Myeloma Treatment Options and Side Effect Management
3
FDA Accepts Application for Padcev Plus Keytruda For Some With Bladder Cancer
4
Alecensa Improves 4-Year Survival in Early ALK-Positive Lung Cancer
5
